Buccal Drug Delivery Market would grow upto USD 7.13 Billion by 2030
Global Buccal Drug Delivery Market research report is a comprehensive synopsis on the study of Healthcare industry and its influence on the market environment. Some of the competitor strategies can be mentioned here as new product launches, expansions, agreements, partnerships, joint ventures, and acquisitions. This market report is a clear-cut solution which can be adopted by businesses to thrive in this swiftly changing marketplace. Not to mention all the topics included have been watchfully analysed with the best tools and techniques. Utilization of well established tools and techniques in the comprehensive Global Buccal Drug Delivery Market report helps to turn complex market insights into simpler version.
Data Bridge Market Research analyses a growth rate in the buccal drug delivery market in the forecast period 2023-2030. The expected CAGR of buccal drug delivery market is tend to be around 9.8% in the mentioned forecast period. The market value is USD 3.38 billion in 2022, and it would grow upto USD 7.13 billion by 2030. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Download PDF Sample Report (Including Graphs, Charts, and List of Figures) @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-buccal-drug-delivery-market&Shri
Buccal drug delivery systems have gained huge growth because of the constant research and development in this field. Buccal delivery is considered the most feasible and preferred choice compared to oral dosage form, particularly among elderly patients. The sublingual films segment is projected to grow at the highest rate during the forecast period 2023-2030. The market is still developing in terms of new product launches because of the limited identification of suitable drug candidates.
Drivers
- Increasing research by Different Community Hospitals
Rise in admission in hospitals, particularly of elderly patients, and product development and research by numerous community hospitals are increasing the segment growth. Studies conducted by several hospitals bring novelty and increase the commercialization of the formulation. For instance, three community hospitals in Japan in 2020 conducted in vitro and in vivo studies to develop mucoadhesive microparticle-laden gels for oral mucositis. The research confirmed that the drug’s increased concentration at the target site and faster treatment than traditional dosage forms are most likely to improve the adoption. Furthermore, several hospitals in highly developed countries are much involved in the study and development of buccal mucoadhesive formulation which includes potent analgesics, insulin, and drugs to treat heart failure. Ambulatory centers are anticipated to witness the huge growth during the forecast period, followed by the other segment that includes home health, clinics, and OTC medications.
Opportunities
- Increasing Demand of Sublingual Films
The sublingual films are anticipated to grow at the highest rate during the forecast period 2023-2030. Multiple factors are responsible for the segment’s growth, such as increased research to develop controlled release formulation and immediate availability of high drug concentration at a target site. These formulations are used widely being used in anti-addiction treatments and emergency care centers due to their faster onset of action.
- Increase in Smoking Addiction
Buccal drug delivery is often the most recommended and effective formulation for treating patients with smoking or nicotine addiction. Several studies have confirmed that nicotine lozenges are highly effective in delivering a greater concentration of the drug than gums or other dosage forms. It is also a good alternative for those hesitant to constantly chew on gums and a great choice to cease low and high-dependent smoking. Thus, this factor boost the market growth.
Market Scenario:
Buccal drug delivery is a substitute technique for an oral drug delivered in which the drug is administrated through buccal mucosa of oral cavity. The drug is usually placed between the upper gums and cheeks for the treatment of numerous disease and condition. Buccal drug delivery is considered suitable for use among the hospital patients. The biofluid interaction of the buccal drug delivery is reduced by such delivery systems. These systems even help in providing high concentration particularly at target area.
Key players operating in the buccal drug delivery market include:
- Pfizer Inc. (U.S.)
- Lupin (India)
- Teva Pharmaceuticals Industries Ltd. (Israel)
- Zydus Group (India)
- Bausch Health Companies Inc (Canada)
- Collegium Pharmaceutical, Inc. (U.S.)
- GSK plc (U.K.)
- Abbvie, Inc (U.S.)
- AstraZeneca (U.K.)
- F. Hoffmann-La Roche Ltd. (Switzerland)
- Mylan N.V. (U.S.)
- Dr. Reddy’s Laboratories Ltd (India)
- Endo International plc (Ireland)
- Sanofi (France)
- Bayer AG (Germany)
- Takeda Pharmaceutical Company Limited (Japan)
- Novartis AG (Switzerland)
- Indivior PLC (U.S.)
- Novo Nordisk A/S (Denmark)
- NAPP PHARMACEUTICALS LIMITED (U.S.)
- APR (Switzerland)
- ARKRAY, Inc (Japan)
To Gain More Insights into the Market Analysis, Browse the Summary of the Research Report@ https://www.databridgemarketresearch.com/reports/global-buccal-drug-delivery-market?Shri
Buccal Drug Delivery Market Scope
Indication
- Pain Management
- Smoking Cessation
- Angina Pectoris
- Cough
- Others
Type
- Non-Attached Drug Delivery Systems
- Bio-Adhesive Drug Delivery Systems
Design
- Matrix Type
- Reserviour Type
Forms
- Solid Buccal Adhesive Dosage Forms
- Buccal tablets
- Wafers
- Lozenges
- Semi-Solid Buccal Adhesive Dosage Forms
- Gels
- Buccal patches
- Buccal films
- Liquid Buccal Adhesive Dosage Forms
Drugs
- Oral Bioadhesive Formulation
- Hydrocartisone succinate
- Hypromellose
- Miconazole
- Chlorohexidine
- Sublingual Formulation
- Glycerin trinitrate
- Others
- Others
End-Users
- Hospitals
- Homecare
- Specialty Clinics
- Others
The report provides insights on the following pointers:
- Market Penetration: Comprehensive information on the product portfolios of the top players in the this research report
- Product Development/Innovation: Detailed insights on upcoming technologies, R&D activities, and product launches in the market
- Competitive Assessment: In-depth assessment of the market strategies, and geographic and business segments of the leading players in the market
- Market Development: Comprehensive information about emerging markets. This report analyzes the market for various segments across geographies
Top Key Topics Covered:
- Strategic Imperatives
- Factors Creating Pressure on Growth
- The Strategic Imperative
- Growth Opportunities Fuel the Growth Pipeline Engine
- Research Methodology
- Scope and Segmentation
- Research Context and Scope of Analysis
- Segmentation
- Other Techniques for This Research Report Management
- Growth Opportunity Analysis
- Growth Drivers
- Growth Restraints
- Introduction
- The Impact of the COVID-19 Pandemic and Post
- Future Growth
- Innovation Ecosystem
Continued…
Browse Detailed Summary of Research Report with TOC: https://www.databridgemarketresearch.com/toc/?dbmr=global-buccal-drug-delivery-market&Shri
Some of the Most Important Questions Scrutinized in the Business Intelligence Report:
- What are the key growth parameters for this global market during the forecast period?
- Which key players are expected to hold the largest market share over the forecast period?
- Who are the leading vendors and manufacturers in this market?
- What are the key strategies adopted by leading players in the market for business development and geographical expansion?
- Which end-use industries can trigger high demand in the market over the forecast period?
- What are the key segments in this market?
- Which regional player will have anticipated leading the global market in terms of size?
- What is the impact of the novel coronavirus pandemic?
- Which obstacles must new players overcome in order to occupy a major position?
Top DBMR Healthcare Reports:
https://www.databridgemarketresearch.com/reports/global-cardasil-treatment-market?Shri
https://www.databridgemarketresearch.com/reports/global-aestheticcosmetic-lasers-market?Shri
https://www.databridgemarketresearch.com/reports/global-yeast-infection-market?Shri
About Data Bridge Market Research:
An absolute way to forecast what future holds is to comprehend the trend today!
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavours to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.
Data Bridge Market Research has over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies globally and have a network of more than 5000+ clientele around the globe. Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate.
Contact Us:-
Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Editor Details
-
Company:
- The Wire Times
